This is to inform you that pursuant to the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct of Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited ("the Company") will remain closed for Insiders, Designated Persons and its immediate relatives of the Compnay with effect from October 01, 2023 till completion of 48 hours after the announcement of the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023 generally made available to the public.